TABLE OF CONTENTS
Volume 3, Issue 1 (2003)
In This Issue |
News and Commentaries |
Perspective |
Clinical Implication |
EELS (Ethical, Economic, Legal & Social) Article |
Original Articles
Editorial
The Pharmacogenomics Journal: the official journal of the International Society of Pharmacogenomics (ISP) FREE
Julio Licinio
Pharmacogenomics J 3: 1; doi:10.1038/sj.tpj.6500165
In This Issue
Top of pageNews and Commentaries
Cytochrome P450 3A pharmacogenetics: the road that needs traveled FREE
D A Flockhart and J M Rae
Pharmacogenomics J 3: 3-5; doi:10.1038/sj.tpj.6500144
Polymorphic CYP2A6 and its clinical and toxicological significance FREE
A Rautio
Pharmacogenomics J 3: 6-7; doi:10.1038/sj.tpj.6500154
Perspective
The challenges of recording phenotype in a generalizable and computable form FREE
P M Nadkarni
Pharmacogenomics J 3: 8-10; doi:10.1038/sj.tpj.6500153
Clinical Implication
Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics FREE
L A Rohde, T Roman and M H Hutz
Pharmacogenomics J 3: 11-13; doi:10.1038/sj.tpj.6500158
EELS (Ethical, Economic, Legal & Social) Article
Pharmacogenetics: the ethical issues FREE
P Lipton
Pharmacogenomics J 3: 14-16; doi:10.1038/sj.tpj.6500159
Original Articles
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients FREE
M Holthe, T N Rakvåg, P Klepstad, J R Idle, S Kaasa, H E Krokan and F Skorpen
Pharmacogenomics J 3: 17-26; doi:10.1038/sj.tpj.6500139
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse FREE
E Lehrmann, J Oyler, M P Vawter, T M Hyde, B Kolachana, J E Kleinman, M A Huestis, K G Becker and W J Freed
Pharmacogenomics J 3: 27-40; doi:10.1038/sj.tpj.6500146
Analysis of gene expression in carbon tetrachloride-treated rat livers using a novel bioarray technology FREE
M B Young, M R DiSilvestro, T J Sendera, J Freund, A Kriete and S R Magnuson
Pharmacogenomics J 3: 41-52; doi:10.1038/sj.tpj.6500147
